We’re proud to have been shortlisted for the @KPMG competition. Good luck to Neciah who’s pitching our business today and everyone else who’s been shortlisted!
Want to learn more about our #AMRConference#startup winner @fluoretiQ? In a short interview CEO Neciah Dorh explains how the technology helps to reduce the time to diagnose bacterial infections #diagnostics#AMR#UTI https://t.co/8Fs0hu8pwY
And the winner is... (drum rolls please) 🥁🥁🥁
‼️ @fluoretiQ ‼️
Hats off to this #StartUp revolutionising bacterial diagnostics for taking home the Winner Prize of the #AMRConference Start-up Campus!
Stay up-to-date, + insights will be published soon: https://t.co/3FPnEjcQaw
FluoretiQ @fluoretiQ is winner of the @AMR_Conference Start-up campus #pitch session! Huge congrats to Neciah Dorh, CEO & Co-Founder of FluoretiQ! 🎉
Antibiotics are a common prescription for people with #COVID19.
But this is raising the risk that more bacteria will become resistant, undermining hospital care globally | @marynmck#StopSuperbugs
https://t.co/nlOaMEu6vV
#COVID19 virus causes some flu-like symptoms. It’s important to remember not to take antibiotics to treat #COVID19. They won’t work and increase the risk of antimicrobial resistance #AMR.
Find out more in the thread ⬇️
(1/3)
Bristol is a hub of activity for research into antibiotic resistance. We examined four innovators in the region, all hoping to reduce the demand for antibiotics.
https://t.co/dtJRYP8dop
Bristol scientists are working to reduce the demands on antibiotics. From 'molecular tyre shredders’ to ‘making bacteria self-digest', we cover the latest tech being developed in the city. Read more in the second part of our antibiotic resistance series: https://t.co/dtJRYP8dop
A new simple blood test for brain tumours that could be used by GPs in primary care is being developed thanks to @CR_UK funding of nearly £500,000
https://t.co/UVhRDTgB2V